ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
OncoQR ML's Vaccine Platform Closes the Final Gap in the Immunological Attack Against Cancer
September 25, 2017OncoQR ML GmbH announced today that even a single therapeutic vaccine based on its proprietary S-TIR™ platform technology, is able to induce the killing of tumor target expressing cells by simultaneously activating all possible immunological pathways
Pharma Sources Insight January 2025
